You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Time to Optimize Deescalation Strategies in Triple-Negative Breast Cancer?
|
---|---|
Published in |
Clinical Cancer Research, September 2022
|
DOI | 10.1158/1078-0432.ccr-22-2140 |
Pubmed ID | |
Authors |
Priyanka Sharma |
X Demographics
The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Mexico | 3 | 19% |
Ireland | 2 | 13% |
Italy | 1 | 6% |
France | 1 | 6% |
United Kingdom | 1 | 6% |
Brazil | 1 | 6% |
United States | 1 | 6% |
Unknown | 6 | 38% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 7 | 44% |
Scientists | 5 | 31% |
Practitioners (doctors, other healthcare professionals) | 4 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 17 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 4 | 24% |
Unspecified | 1 | 6% |
Student > Ph. D. Student | 1 | 6% |
Other | 1 | 6% |
Unknown | 10 | 59% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 2 | 12% |
Medicine and Dentistry | 2 | 12% |
Biochemistry, Genetics and Molecular Biology | 1 | 6% |
Immunology and Microbiology | 1 | 6% |
Unspecified | 1 | 6% |
Other | 0 | 0% |
Unknown | 10 | 59% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 September 2022.
All research outputs
#4,173,273
of 25,382,035 outputs
Outputs from Clinical Cancer Research
#3,860
of 13,228 outputs
Outputs of similar age
#79,466
of 426,206 outputs
Outputs of similar age from Clinical Cancer Research
#79
of 135 outputs
Altmetric has tracked 25,382,035 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,228 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.7. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 426,206 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 135 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.